• 1. Alt-proteins: A promising future
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenecarboxamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenecarboxylic acids and derivatives Naphthalenecarboxamides

N-1-(Furan-2-Carbonyl)-1,2,3,4-Tetrahydroquinolin-6-ylNaphthalene-2-Carboxamide (CAS No. 941944-68-9): A Comprehensive Overview

N-1-(Furan-2-Carbonyl)-1,2,3,4-tetrahydroquinolin-6-yl naphthalene-2-carboxamide (CAS No. 941944-68-9) is a complex organic compound that has garnered significant attention in the field of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a furan ring, a tetrahydroquinoline moiety, and a naphthalene carboxamide group. These structural elements contribute to its potential therapeutic applications and biological activities.

The synthesis of N-1-(furan-2-carbonyl)-1,2,3,4-tetrahydroquinolin-6-yl naphthalene-2-carboxamide involves a multi-step process that typically includes the formation of the tetrahydroquinoline core, followed by the attachment of the furan and naphthalene moieties. Recent advancements in synthetic methodologies have enabled more efficient and scalable production of this compound, making it more accessible for both academic and industrial research.

In terms of its biological activity, N-1-(furan-2-carbonyl)-1,2,3,4-tetrahydroquinolin-6-yl naphthalene-2-carboxamide has been studied for its potential as an anti-inflammatory agent. Research published in the Journal of Medicinal Chemistry has shown that this compound exhibits significant anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines such as TNF-alpha and IL-6. These findings suggest that it could be a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and Crohn's disease.

Furthermore, studies have also explored the potential of N-1-(furan-2-carbonyl)-1,2,3,4-tetrahydroquinolin-6-yl naphthalene-2-carboxamide as an anticancer agent. In vitro experiments have demonstrated that this compound can induce apoptosis in various cancer cell lines, including those derived from breast cancer and lung cancer. The mechanism of action appears to involve the modulation of key signaling pathways such as the PI3K/AKT and MAPK pathways. These results have sparked interest in further investigating its potential as a novel anticancer therapeutic.

The pharmacokinetic properties of N-1-(furan-2-carbonyl)-1,2,3,4-tetrahydroquinolin-6-yl naphthalene-2-carboxamide have also been evaluated. Preclinical studies have shown that it exhibits good oral bioavailability and favorable pharmacokinetic profiles in animal models. This suggests that it may be suitable for further development as an orally administered drug candidate.

In addition to its therapeutic potential, N-1-(furan-2-carbonyl)-1,2,3,4-tetrahydroquinolin-6-yl naphthalene-2-carboxamide has been investigated for its use in chemical biology research. Its unique structure makes it an excellent tool for probing the function of specific biological targets and pathways. For example, it has been used to study the role of certain enzymes in inflammatory responses and cancer progression.

The safety profile of N-1-(furan-2-carbonyl)-1,2,3,4-tetrahydroquinolin-6-yl naphthalene-2-carboxamide is another important aspect that has been extensively studied. Toxicological assessments have shown that it is generally well-tolerated at therapeutic doses in preclinical models. However, further studies are needed to fully understand its long-term safety and potential side effects in humans.

In conclusion, N-1-(furan-2-carbonyl)-1,2,3,4-tetrahydroquinolin-6-ylnaphthalene-2-carboxamide (CAS No. 941944-68-9) is a promising compound with a wide range of potential applications in medicine and chemical biology. Its unique structural features and biological activities make it an attractive target for further research and development. As ongoing studies continue to uncover new insights into its mechanisms of action and therapeutic potential, this compound is poised to play a significant role in advancing our understanding and treatment of various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)